A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry
- Creator: Spelman, Tim , Ozakbas, Serkan , Soysal, Aysun , Kuhle, Jens , Sanchez-Menoyo, Jose Luis , Morgado, Yolanda Blanco , Spitaleri, Daniele L. A. , Pesch, Vincent Van , Horakova, Dana , Ampapa, Radek , Patti, Francesco , Macdonell, Richard , Alroughani, Raed , Al-Asmi, Abdullah , Gerlach, O , Oh, J , Altintas, A , Tundia, N , Wong, SL , Butzkueven, H , MSBase Study Group, , Terzi, Murat , Hodgkinson, Suzanne , Laureys, Guy , Kalincik, Tomas , Der Walt, Anneke Van , Yamout, Bassem , Lechner-Scott, Jeannette
- Resource Type: journal article
- Date: 2023
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
- Creator: Kalincik, Tomas , Sharmin, Sifat , Grigg, Andrew , Torkildsen, Øivind , Bo, Lars , Lehmann, Anne Kristine , Havrdova, Eva Kubala , Krasulova, Eva , Trnený, Marek , Kozak, Tomas , van der Walt, Anneke , Butzkueven, Helmut , Roos, Izanne , McCombe, Pamela , Skibina, O , Lechner-Scott, Jeanette , Willekens, B , Cartechini, E , Ozakbas, S , Alroughani, R , Kuhle, J , Patti, F , Duquette, P , Freedman, Mark S. , Lugaresi, A , Khoury, SJ , Slee, M , Turkoglu, R , Hodgkinson, S , John, N , Maimone, D , Sa, MJ , van Pesch, V , Gerlach, O , Atkins, Harold , Laureys, G , Van Hijfte, L , Karabudak, R , Spitaleri, D , Csepany, T , Gouider, R , Castillo-Triviño, T , Taylor, B , Sharrack, B , Snowden, JA , Burman, Joachim , MSBase Study Group Collaborators, , MSBase Study Group Authors, , Mrabet, S , Garber, J , Sanchez-Menoyo, JL , Aguera-Morales, E , Blanco, Y , Al-Asmi, A , Weinstock-Guttman, B , Fragoso, Y , Massey, Jennifer , de Gans, K , Kermode, A , MSBase Study Group, , Sutton, Ian , Withers, Barbara , Macdonell, Richard
- Resource Type: journal article
- Date: 2023
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
- Creator: Spelman, Tim , Ozakbas, Serkan , Soysal, Aysun , Kuhle, Jens , Sanchez-Menoyo, Jose Luis , Blanco Morgado, Yolanda , Spitaleri, Daniele L. A. , van Pesch, Vincent , Horakova, Dana , Ampapa, Radek , Patti, Francesco , Macdonell, Richard , Alroughani, Raed , Al-Asmi, A , Gerlach, O , Oh, J , Altintas, A , Tundia, N , Wong, SL , Butzkueven, H , Terzi, Murat , Hodgkinson, Suzanne , Laureys, Guy , Kalincik, Tomas , Van Der Walt, Anneke , Yamout, Bassem , Lechner-Scott, Jeannette
- Resource Type: journal article
- Date: 2023
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
- Creator: Zhu, Chao , Zhou, Zhen , Roos, Izanne , Merlo, Daniel , Kalincik, Tomas , Ozakbas, Serkan , Skibina, Olga , Kuhle, Jens , Hodgkinson, Suzanne , Boz, Cavit , Alroughani, Raed , Lechner-Scott, Jeannette , Barnett, Michael , Izquierdo, Guillermo , Prat, Alexandre , Horakova, Dana , Havrdova, Eva Kubala , Macdonell, Richard , Patti, Francesco , Khoury, Samia Joseph
- Resource Type: journal article
- Date: 2022
Prediction of multiple sclerosis outcomes when switching to ocrelizumab
- Creator: Zhong, Michael , van der Walt, Anneke , Macdonell, Richard , Prevost, Julie , Kuhle, Jens , Laureys, Guy , Van Hijfte, Liesbeth , Alroughani, Raed , Kermode, Allan G. , Butler, Ernest , Barnett, Michael , Eichau, Sara , Stankovich, Jim , van Pesch, V , Grammond, P , McCombe, P , Karabudak, R , Duquette, P , Girard, M , Taylor, B , Yeh, W , Monif, M , Gresle, M , Kalincik, Tomas , Butzkueven, H , Jokubaitis, VG , Buzzard, Katherine , Skibina, Olga , Boz, Cavit , Hodgkinson, Suzanne , Slee, Mark , Lechner-Scott, Jeanette
- Resource Type: journal article
- Date: 2022